Delivery Order SPE2DB22D7058-SPE2DB23FSUC1
Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $17K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $17,773 to Amerisourcebergen Drug Corporation to provide 100 mg vials of the pharmaceutical ACTIVASE. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 25 to June 26, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $6,237.63 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Activase 100 mg vials, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $17,761 to Amerisourcebergen Drug Corporation to supply 100mg vials of the pharmaceutical ACTIVASE. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 25, 2023 under the parent company Amerisourcebergen Corporation's indefinite-delivery/indefinite-quantity prime vendor contract. No subcontractors or set aside designations were indicated. The DLA manages...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $34,134.85 contract is for the supply of ACTIVASE 100 MG VIALS, a pharmaceutical product, with a completion date of January 16, 2024. This delivery order is part of Amerisourcebergen Drug Corp's broader work providing pharmaceuticals, medical supplies, and distribution...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $12,171.70 to Amerisourcebergen Drug Corporation to provide 100 mg vials of the drug Activase. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 26, 2023 through June 27, 2023. The delivery order was awarded under the DLA's indefinite-delivery/indefinite-quantity pharmaceutical prime vendor contract vehicle, which...
- The Defense Logistics Agency awarded a $10,005.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561418742 ACTIVASE 50 MG VIALS. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 7, 2023 to support DLA programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract vehicle to fulfill requirements for Activase, a medication used to treat...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $38,853.47 to Amerisourcebergen Drug Corporation to supply 4561425706 units of 50 mg vials of the drug Activase. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 7-10, 2023. This delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to support the medical...
- The Defense Logistics Agency issued a $35,987.68 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for ACTIVASE 100 MG vials, with final delivery due February 6, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. Pricing is firm fixed...
- This is a $14,164.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 100 mg vials of the pharmaceutical product ACTIVASE. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for the provision of a comprehensive range of medical commodities to support military treatment programs and...
- The Defense Logistics Agency awarded a $33,311.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Activase 100 mg vials, with performance completion targeted for October 29, 2025. The award, issued without a set-aside designation, reflects open competitive procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...